Corrigendum: Natural killer cells from patients with recombinase-activating gene and non-homologous end joining gene defects comprise a higher frequency of CD56bright NKG2A+++ cells, and yet display increased degranulation and higher perforin content [Front Immunol, 8, (2017), (798)] doi: 10.3389/fimmu.2017.00798

Kerry Dobbs, Giovanna Tabellini, Enrica Calzoni, Ornella Patrizi, Paula Martinez, Silvia Clara Giliani, Daniele Moratto, Waleed Al-Herz, Caterina Cancrini, Morton Cowan, Jacob Bleesing, Claire Booth, David Buchbinder, Siobhan O. Burns, Talal A. Chatila, Janet Chou, Vanessa Daza-Cajigal, Lisa M.Ott de Bruin, Maite Teresa de la Morena, Gigliola Di MatteoAndrea Finocchi, Raif Geha, Rakesh K. Goyal, Anthony Hayward, Steven Holland, Chiung Hui Huang, Maria G. Kanariou, Alejandra King, Blanka Kaplan, Anastasiya Kleva, Taco W. Kuijpers, Bee Wah Lee, Vassilios Lougaris, Michel Massaad, Isabelle Meyts, Megan Morsheimer, Benedicte Neven, Sung Yun Pai, Nima Parvaneh, Alessandro Plebani, Susan Prockop, Ismail Reisli, Jian Yi Soh, Raz Somech, Troy R. Torgerson, Yae Jean Kim, Jolan E. Walter, Andrew R. Gennery, Sevgi Keles, John P. Manis, Emanuela Marcenaro, Alessandro Moretta, Silvia Parolini, Luigi D. Notarangelo

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations

Abstract

There was a mistake in the authorship. The name of Nima Parvaneh was unintentionally omitted. Dr. Parvaneh has contributed biological specimens and clinical and immunological data from patient P66 included in the manuscript, and as such he should be included in the authorship. The authors apologize for the mistake. This error does not change the scientific conclusions of the article in any way. With the inclusion of Dr. Parvaneh's name in the authorship, the paragraph of Author Contributions should also be corrected as follows: JM, EM, AM, SP, and LN designed the study, interpreted the data, and wrote the manuscript; KD, GT, EC, OP, PM, SG, and DM performed experiments, acquired and analyzed the data; WA-H, CC, MC, JB, CB, DB, SB, TC, JC, VD-C, LOdB, MTdlM, GM, AF, RG, RKG, AH, SH, C-HH, MK, AlKi, BK, AnKl, TK, BL, VL, MiMa, IM, MeMo, BN, S-YP, NP, AP, SP, IR, JS, RS, TT, Y-JK, JW, AG, and SK contributed patient samples and clinical and immunological data; all authors have revised the work for its intellectual content, have approved its final version and have agreed to be accountable for all aspects related to the accuracy and integrity of the work. This correction does not change the scientific conclusions of the article in any way. Author apologizes for these errors and thank you for your consideration. The original has been updated.

Original languageEnglish (US)
Article number1244
JournalFrontiers in immunology
Volume8
Issue numberOCT
DOIs
StatePublished - Oct 10 2017

Keywords

  • CD56
  • Degranulation
  • Immunodeficiency
  • Interferon-γ
  • Natural killer cells
  • Non-homologous end joining
  • Recombinase-activating genes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Corrigendum: Natural killer cells from patients with recombinase-activating gene and non-homologous end joining gene defects comprise a higher frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> cells, and yet display increased degranulation and higher perforin content [Front Immunol, 8, (2017), (798)] doi: 10.3389/fimmu.2017.00798'. Together they form a unique fingerprint.

Cite this